Breaking News
0
Ad-Free Version. Subscribe now to follow markets, faster and distraction-free. More details
Close

Immunic Inc (IMUX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Immunic's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.99 +0.19    +1.28%
05/03 - Closed. Currency in USD ( Disclaimer )
After Hours
15.44
+0.45
+3.00%
05/03
Type:  Equity
Market:  United States
ISIN:  US4525EP1011 
CUSIP:  4525EP101
  • Volume: 310,937
  • Bid/Ask: 14.50 / 15.45
  • Day's Range: 13.07 - 15.32
Immunic 14.99 +0.19 +1.28%
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close14.8
Day's Range13.07 - 15.32
RevenueN/A
Open14.97
52 wk Range4.19 - 27.61
EPS - 2.93
Volume310,937
Market Cap317.31M
Dividend (Yield)N/A (N/A)
Average Volume (3m)264,873
P/E RatioN/A
Beta2.16
1-Year Change87.84%
Shares Outstanding21,168,240
Next Earnings DateMay 07, 2021
What is your sentiment on Immunic?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Buy Buy Neutral Strong Sell Strong Sell
Technical Indicators Strong Buy Strong Buy BUY Strong Sell Strong Sell
Summary Strong Buy Strong Buy Neutral Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Hammer 1D Current
Three Black Crows 1W Current
Engulfing Bearish 1M Current
Completed Patterns
Falling Three Methods 1W 1 Feb 21, 2021
Advance Block Bearish 1H 1 Mar 05, 2021 20:00
Doji Star Bearish 1H 1 Mar 05, 2021 20:00

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  FBN Holdings 7.10 7.10 6.85 +0.05 +0.71% 26.50M 05/03  
  MTN Nigeria 160.20 160.20 160.20 -9.80 -5.76% 643.20K 05/03  
  Guaranty Trust Bank 31.20 31.05 30.90 -0.50 -1.59% 20.83M 05/03  
  Zenith Bank 25.30 25.40 24.95 0.00 0.00% 46.85M 05/03  
  UBA 7.95 7.95 7.85 0.00 0.00% 23.30M 05/03  
  Access Bank 7.90 7.85 7.70 +0.10 +1.28% 10.47M 05/03  
  Dangote Sugar 16.90 16.90 16.40 +0.40 +2.42% 1.98M 05/03  
  Lafarge Africa 22.20 22.20 21.80 +2.00 +9.90% 1.65M 05/03  
  STANBIC IBTC Bank 44.00 44.00 44.00 +4.00 +10.00% 82.37K 05/03  
  Oando Plc 2.65 3.00 2.65 -0.25 -8.62% 4.05M 05/03  

Immunic Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

26

Equity Type

ORD

Immunic, Inc., formerly Vital Therapies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The Company is developing three small molecule products: IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. The Company’s lead development program, IMU-838, is in Phase II clinical development for ulcerative colitis and relapsing-remitting multiple sclerosis, with an additional Phase II trial in Crohn’s disease.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IMUX Comments

Write your thoughts about Immunic Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email